Skip to main content
OpenTrials
Completed

NCT Number: NCT06124131

Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening

The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are:

* Do patient financial incentives for completing colorectal cancer screening increase screening completion? * Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots?

Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment.

Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Health Behavior Behavior COVID-19 Colonic Diseases Colorectal Cancer Colorectal Neoplasms Coronaviridae Infections Coronavirus Infections Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Healthcare Patient Acceptance Infections Influenza Influenza, Human Intestinal Diseases Intestinal Neoplasms Lung Diseases Neoplasms Neoplasms by Site Nidovirales Infections Orthomyxoviridae Infections Patient Acceptance of Health Care Pneumonia Pneumonia, Viral RNA Virus Infections Rectal Diseases Respiratory Tract Diseases Respiratory Tract Infections Treatment Adherence and Compliance Treatment Refusal Vaccination Hesitancy Vaccination Refusal Vaccine Hesitancy Vaccine-Preventable Diseases Virus Diseases

Age range

45 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tulane University School of Medicine

New Orleans, Louisiana, 70112, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 45 to 75
  • Receive care at participating primary care clinic
  • Due for colorectal cancer screening
  • Ability to understand and speak English

Exclusion criteria

  • Currently participating in another clinical trial or research study on colorectal cancer screening
  • Unable or unwilling to give informed consent

Treatment and study plan

Financial incentive for colorectal cancer screening

Behavioral

$50 incentive paid to participant for completion of colorectal cancer screening within 2 months of enrollment

Financial incentive for flu shot

Behavioral

$50 incentive paid to participant for completion of flu shot within 2 months of enrollment

Financial incentive for COVID-19 shot

Behavioral

$50 incentive paid to participant for completion of COVID-19 shot within 2 months of enrollment

Primary outcomes

  1. Difference in Percent of Participants Completing Colorectal Cancer Screening Between Study Arms

    Time frame: Two months

    Completion of colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test as documented in electronic health record within two months of study enrollment

Secondary outcomes

  1. Difference in Percent of Participants Completing COVID-19 Shot Between Study Arms

    Time frame: Two months

    Completion of COVID-19 shot as documented in electronic health record within two months of study enrollment

  2. Difference in Percent of Participants Completing Flu Shot Between Study Arms

    Time frame: Two months

    Completion of flu shot as documented in electronic health record within two months of study enrollment

  3. Difference in Percent of Participants Completing at Least One of the Following Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot

    Time frame: Two months

    Completion of colorectal cancer screening (colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test), COVID-19 shot, *OR* flu shot as documented in electronic health record within two months of study enrollment

  4. Difference in Percent of Participants Completing All Three Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot

    Time frame: Two months

    Completion of colorectal cancer screening (colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test), COVID-19 shot, *AND* flu shot as documented in electronic health record within two months of study enrollment

Other outcomes

  1. Number of Patients Reached for Recruitment

    Time frame: Three months

    Number of patients reached for recruitment

  2. Number of Patients Assessed for Eligibility

    Time frame: Three months

    Number of patients assessed for eligibility

  3. Number of Patients Consented and Randomized

    Time frame: Three months

    Number of patients consented and randomized

  4. Number of Patients Who Receive the Outreach Call Intervention

    Time frame: Three months

    Number of patients who receive the outreach call intervention

Sponsors and collaborators

Lead sponsor

Tulane University

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Acronym: BENEFIT-C

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Nov 9, 2023
Registry last updated
May 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.